News · HER2
189 stories
Oct 13, 26Vir CEO sees ‘opportunity to do more deals’ after striking $1.9B Gilead pact for dual-masked TCEs
Oct 2, 26Moderna, Neurocrine bring back familiar faces; Pharming CEO exits after clashing with board
Sep 17, 26STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal
Sep 14, 26AstraZeneca’s newly approved cancer pill fails late-stage study, blocking path to bigger market
Sep 8, 26Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy